| Related Articles |
Coagulopathic hemorrhage with use of synthetic cannabinoids.
Am J Emerg Med. 2018 Oct 16;:
Authors: Boyack I, Opsha O
Abstract
Synthetic cannabinoids contain many different chemicals and compounds, which pose new health risks to the population using these drugs. In May of 2018 the Center for Disease Control issued a health alert providing information on a multistate outbreak of coagulopathy from exposure to synthetic cannabinoid products containing a Vitamin K-dependent antagonistic agent such as brodifacoum. Recognizing signs, symptoms and imaging findings related to this outbreak is essential for clinicians caring for patients with a history or suspicion of using synthetic cannabinoids. To our knowledge, there are no studies that report the imaging findings demonstrating the coagulopathic complications associated with these synthetic compounds.
PMID: 30409461 [PubMed - as supplied by publisher]